---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-009862"
form_type: "8-K"
ticker: "AARD"
cik: "0001774857"
company_name: "Aardvark Therapeutics, Inc."
filed_at: "2026-01-12T23:59:59+00:00"
generated_at: "2026-05-16T10:54:56.848446+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "low"
source: SEC EDGAR
---

# Aardvark Therapeutics files updated corporate presentation; no material disclosures.

## Summary
- Updated corporate presentation dated January 2026 filed with SEC.
- No specific operational, financial, or clinical updates disclosed in the filing.
- Presentation intended for use in investor meetings and posted to company website.

## SEC filing metadata
- accession: 0001193125-26-009862
- form_type: 8-K
- ticker: AARD
- cik: 0001774857
- company_name: Aardvark Therapeutics, Inc.
- filed_at: 2026-01-12T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1774857/000119312526009862/0001193125-26-009862-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1774857/000119312526009862/ck0001774857-20260112.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-009862
- JSON: https://secwatch.observer/filing/0001193125-26-009862.json
- Plain text: https://secwatch.observer/filing/0001193125-26-009862.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.